Analyst Recommendations

UBS analyst issues NEUTRAL recommendation for HPQ on August 29, 2024 08:37AM ET. The previous analyst recommendation was Neutral.HPQ was trading at $34.76 at issue of the analyst...

August 29, 2024   HPQ -0.97%

UBS analyst issues BUY recommendation for STNE on August 29, 2024 08:39AM ET. The previous analyst recommendation was Buy.STNE was trading at $13.02 at issue of the analyst...

August 29, 2024   STNE -3.61%

Raymond James analyst issues OUTPERFORM recommendation for CARE on August 29, 2024 08:37AM ET. The previous analyst recommendation was Outperform.CARE was trading at $16.94 at issue of the...

August 29, 2024   CARE -0.38%

UBS analyst issues NEUTRAL recommendation for CHWY on August 29, 2024 08:37AM ET. The previous analyst recommendation was Neutral.CHWY was trading at $28.72 at issue of the analyst...

August 29, 2024   CHWY -4.35%

Raymond James analyst issues OUTPERFORM recommendation for CSR on August 29, 2024 08:43AM ET. The previous analyst recommendation was Outperform.CSR was trading at $74.51 at issue of the...

August 29, 2024   CSR -2.03%

Raymond James analyst issues OUTPERFORM recommendation for CRWD on August 29, 2024 08:40AM ET. The previous analyst recommendation was Outperform.CRWD was trading at $264.2 at issue of the...

August 29, 2024   CRWD -4.48%

Raymond James analyst issues OUTPERFORM recommendation for ESS on August 29, 2024 08:44AM ET. The previous analyst recommendation was Outperform.ESS was trading at $296.09 at issue of the...

August 29, 2024   ESS -2.04%

Raymond James analyst issues OUTPERFORM recommendation for VEEV on August 29, 2024 08:45AM ET. The previous analyst recommendation was Outperform.VEEV was trading at $199.35 at issue of the...

August 29, 2024   VEEV -0.48%

Raymond James analyst issues OUTPERFORM recommendation for PSTG on August 29, 2024 08:44AM ET. The previous analyst recommendation was Outperform.PSTG was trading at $59.76 at issue of the...

August 29, 2024   PSTG -4.23%

Exane BNP Paribas analyst issues OUTPERFORM recommendation for CRM on August 29, 2024 08:47AM ET. The previous analyst recommendation was Outperform.CRM was trading at $258.9 at issue of...

August 29, 2024   CRM -0.05%